Table 1.
Study | Analgesic regimen | Route of administration (mode of analgesia) | Findings |
---|---|---|---|
| |||
• Conti et al46 | • Morphinea | • Oral (unimodal) | • Reduction in the number of ED consultations, total number of hours spent in the ED, and proportion of consultations ending with hospital admissions |
• Tawfic et al13 | • Morphine and other adjuvant analgesics • Plus low-dose ketamine– midazolam regimenb |
• Intravenous (multimodal) | • Significant improvement in pain scores of adult SCD patients in severe painful crisis |
• Telfer et al48 | • Diamorphinec • Morphine |
• Intranasal • Intravenous/oral (multimodal) |
• Rapid improvement in pain scores within 2 hours in pediatric SCD patients with painful crisis in an ED |
• Brookoff and Polomano49 | • Morphine | • Intravenous • Oral controlled-release (unimodal) |
• Reduction in number of admissions for pain by 44%, total inpatient days by 57%, hospital LOS by 23%, and ED visits by 67% |
• Buchanan et al51 | • Nalbuphine hydrochlorided | • Parenteral by PCA (unimodal) | • Reduction in hospital LOS • Prevented ACS |
Notes:
Strong opioid;
adjunct treatment;
also known as heroin (more potent than morphine)
opioid with similar pain-relieving potency to morphine.
Abbreviations: ACS, acute chest syndrome; ED, emergency department; LOS, length of stay; PCA, patient-controlled analgesia; SCD, sickle cell disease.